We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITW icon
351
Illinois Tool Works
ITW
$84.1B
$5.44M 0.05%
27,785
– –
TGT icon
352
Target
TGT
$66.3B
$5.39M 0.04%
31,774
– –
AIG icon
353
American International
AIG
$42.5B
$5.38M 0.04%
148,094
– –
IPG
354
DELISTED
Interpublic Group of Companies
IPG
$5.37M 0.04%
237,600
-29
-0% -$765
OKTA icon
355
Okta
OKTA
$23.8B
$5.37M 0.04%
21,976
– –
PFE icon
356
Pfizer
PFE
$143B
$5.29M 0.04%
149,694
– –
ES icon
357
Eversource Energy
ES
$28.1B
$5.26M 0.04%
63,339
– –
INFY icon
358
Infosys
INFY
$51B
$5.23M 0.04%
321,238
– –
AKAM icon
359
Akamai
AKAM
$15.6B
$5.23M 0.04%
51,853
– –
DXCM icon
360
DexCom
DXCM
$29B
$5.23M 0.04%
58,900
– –
TDOC icon
361
Teladoc Health
TDOC
$1.66B
$5.19M 0.04%
27,034
– –
HII icon
362
Huntington Ingalls Industries
HII
$11B
$5.17M 0.04%
31,589
– –
COGT icon
363
Cogent Biosciences
COGT
$6.76B
$5.12M 0.04%
474,809
+79
+0% +$761
LYV icon
364
Live Nation Entertainment
LYV
$42.9B
$5.11M 0.04%
72,353
– –
OTIS icon
365
Otis Worldwide
OTIS
$27.9B
$5.11M 0.04%
78,675
– –
CSX icon
366
CSX Corp
CSX
$94B
$5.06M 0.04%
174,039
+6
+0% +$183
FITB
367
Fifth Third Bancorp
FITB
$51.3B
$5.04M 0.04%
190,296
– –
NTAP icon
368
NetApp
NTAP
$34B
$5.02M 0.04%
78,918
– –
NKTR icon
369
Nektar Therapeutics
NKTR
$2.39B
$5M 0.04%
20,406
– –
EXC icon
370
Exelon
EXC
$48.1B
$4.97M 0.04%
171,836
– –
SCHW
371
Charles Schwab
SCHW
$182B
$4.92M 0.04%
96,577
– –
XYZ
372
Block Inc
XYZ
$48.9B
$4.88M 0.04%
23,368
– –
TNDM icon
373
Tandem Diabetes Care
TNDM
$1.27B
$4.81M 0.04%
52,370
– –
DD icon
374
DuPont de Nemours
DD
$18.6B
$4.75M 0.04%
55,451
– –
MASI
375
DELISTED
Masimo
MASI
$4.69M 0.04%
18,179
– –
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.